These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 2198643

  • 1. [Physiology of fibrinolysis and thrombolytic agents].
    Perego D, Pogliani EM.
    Recenti Prog Med; 1990 Apr; 81(4):276-81. PubMed ID: 2198643
    [Abstract] [Full Text] [Related]

  • 2. [The fibrinolytic system and its activators].
    Seifried E.
    Z Gesamte Inn Med; 1993 Apr; 48(6-7):272-82. PubMed ID: 8333223
    [Abstract] [Full Text] [Related]

  • 3. [Position and developmental trends in fibrinolytic therapy].
    Markwardt F.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986 Apr; 113(1-2):6-17. PubMed ID: 2427416
    [Abstract] [Full Text] [Related]

  • 4. [New thrombolytic agents in myocardial infarction].
    Charbonnier B, Lang M, Brochier M.
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [Abstract] [Full Text] [Related]

  • 5. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN, Kizim AI.
    Vopr Med Khim; 1984 Nov; 30(5):13-22. PubMed ID: 6084892
    [Abstract] [Full Text] [Related]

  • 6. [Laboratory control of fibrinolytic therapy].
    Vinazzer H.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986 Nov; 113(1-2):30-7. PubMed ID: 2427412
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis.
    Marder VJ, Francis CW.
    Prog Hemost Thromb; 1984 Nov; 7():325-56. PubMed ID: 6241729
    [No Abstract] [Full Text] [Related]

  • 9. [Tissue plasminogen activator: mechanism of action and thrombolytic properties].
    Páramo JA, Collen D.
    Sangre (Barc); 1984 Nov; 29(4-C):767-73. PubMed ID: 6393389
    [No Abstract] [Full Text] [Related]

  • 10. [New thrombolytic drugs].
    Kopeć M.
    Pol Tyg Lek; 1984 Nov; 45(6-7):127-30. PubMed ID: 2216951
    [No Abstract] [Full Text] [Related]

  • 11. Fibrin-specific thrombolytic agents.
    Collen D.
    Schweiz Med Wochenschr; 1987 Nov 14; 117(46):1791-8. PubMed ID: 3122317
    [Abstract] [Full Text] [Related]

  • 12. [Thrombolytics and their use].
    Alessi MC, Juhan-Vague I.
    Rev Prat; 1999 Oct 01; 49(15):1654-8. PubMed ID: 10581996
    [Abstract] [Full Text] [Related]

  • 13. Present-day thrombolytic therapy: therapeutic agents--pharmacokinetics and pharmacodynamics.
    Bell WR.
    Rev Cardiovasc Med; 2002 Oct 01; 3 Suppl 2():S34-44. PubMed ID: 12556741
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intraarterial fibrinolysis: in vitro and prospective clinical evaluation of three thrombolytic agents.
    Pilger E, Lammer J, Bertuch H, Steiner H.
    Radiology; 1986 Dec 01; 161(3):597-9. PubMed ID: 3786705
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Problems of thrombolytic therapy.
    Neilson RF, Davidson JF.
    Adverse Drug React Toxicol Rev; 1996 Mar 01; 15(1):51-64. PubMed ID: 8920633
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.